
Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Clinical Research, health outcomes research, health disparities research, patient-reported outcomes, Diseases, real-world evidence, Therapies, registries, Lymphoid Malignancies, Myeloid Malignancies
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Clinical Research, health outcomes research, health disparities research, patient-reported outcomes, Diseases, real-world evidence, Therapies, registries, Lymphoid Malignancies, Myeloid Malignancies
Monday, December 12, 2022: 4:30 PM-6:00 PM
217-219
(Ernest N. Morial Convention Center)
Chair:
William A. Wood, MD, MPH, University of North Carolina at Chapel Hill
Disclosures:
Wood: Pfizer: Research Funding; Genentech: Research Funding; Teladoc: Consultancy; Koneksa Health: Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees; Quantum Health: Consultancy.
See more of: Special-Interest Sessions